Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
SVP, Chief Medical Officer
-
Stock Symbol
-
SUPN on Nasdaq
Jonathan Rubin - trading volume in the past year for Supernus Pharmaceuticals, Inc.
| Security |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
11K |
$509K |
$46.21 |
Sep 25, 2025 |
Direct |
|
|
| Restricted Stock Unit |
2.5K |
$97.9K |
$39.15 |
Feb 23, 2025 |
Direct |
Common Stock |
|
| Performance Share Unit |
0 |
$0 |
$35.59 |
Sep 25, 2025 |
Direct |
Common Stock |
|
| Performance Share Units |
0 |
$0 |
$39.15 |
Feb 21, 2025 |
Direct |
Common Stock |
|
| Employee Stock Option (Right to Buy) |
20K |
|
|
Feb 19, 2025 |
Direct |
Common Stock |
|
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.